These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 23119009)

  • 1. High bone sialoprotein (BSP) expression correlates with increased tumor grade and predicts a poorer prognosis of high-grade glioma patients.
    Xu T; Qin R; Zhou J; Yan Y; Lu Y; Zhang X; Fu D; Lv Z; Li W; Xia C; Hu G; Ding X; Chen J
    PLoS One; 2012; 7(10):e48415. PubMed ID: 23119009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
    Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A
    J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACTC1 as an invasion and prognosis marker in glioma.
    Ohtaki S; Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Noshiro S; Akiyama Y; Mikami T; Mikuni N; Kocsis JD; Honmou O
    J Neurosurg; 2017 Feb; 126(2):467-475. PubMed ID: 27081897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of microRNA-124 predicts poor prognosis in glioma patients.
    Chen T; Wang XY; Li C; Xu SJ
    Neurol Sci; 2015 Jan; 36(1):131-5. PubMed ID: 25112530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
    Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
    Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
    Lai NS; Dong QS; Ding H; Miao ZL; Lin YC
    J Clin Neurosci; 2014 May; 21(5):755-60. PubMed ID: 24382515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corpus callosum involvement and postoperative outcomes of patients with gliomas.
    Chen KT; Wu TW; Chuang CC; Hsu YH; Hsu PW; Huang YC; Lin TK; Chang CN; Lee ST; Wu CT; Tseng CK; Wang CC; Pai PC; Wei KC; Chen PY
    J Neurooncol; 2015 Sep; 124(2):207-14. PubMed ID: 26033546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced expression of microRNA-134 correlates with malignancy and poor prognosis in human glioma.
    Zhong J; Li B
    J Clin Neurosci; 2015 Mar; 22(3):583-7. PubMed ID: 25564273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of microRNA-155 predicts poor prognosis in glioma patients.
    Sun J; Shi H; Lai N; Liao K; Zhang S; Lu X
    Med Oncol; 2014 Apr; 31(4):911. PubMed ID: 24623016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic reg IV is a novel prognostic marker for glioma patient survival.
    Wang Q; Deng J; Yuan J; Wang L; Zhao Z; He S; Zhang Y; Tu Y
    Diagn Pathol; 2012 Jun; 7():69. PubMed ID: 22713481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amide proton transfer imaging might predict survival and IDH mutation status in high-grade glioma.
    Joo B; Han K; Ahn SS; Choi YS; Chang JH; Kang SG; Kim SH; Zhou J; Lee SK
    Eur Radiol; 2019 Dec; 29(12):6643-6652. PubMed ID: 31175415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and survival rates in patients with glioma in China (2004-2010): a retrospective study from a single-institution.
    Yang P; Wang Y; Peng X; You G; Zhang W; Yan W; Bao Z; Wang Y; Qiu X; Jiang T
    J Neurooncol; 2013 Jun; 113(2):259-66. PubMed ID: 23483435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of ubiquitin-specific protease 2a (USP2a) and nuclear factor erythroid 2-related factor 2 (Nrf2) in human gliomas.
    Boustani MR; Khoshnood RJ; Nikpasand F; Taleshi Z; Ahmadi K; Yahaghi E; Goudarzi PK
    J Neurol Sci; 2016 Apr; 363():249-52. PubMed ID: 27000259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multivariate retrospective analysis of high-grade gliomas: Survival and prognostic factors.
    Shi W; Wang X; Liu S; Zheng Z; Dong L; Jiang X
    Cancer Med; 2024 Aug; 13(15):e7456. PubMed ID: 39118481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of microRNA-224 confers a poor prognosis in glioma patients.
    Lu S; Wang S; Geng S; Ma S; Liang Z; Jiao B
    Clin Transl Oncol; 2013 Jul; 15(7):569-74. PubMed ID: 23263909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDAC3 Expression Correlates with the Prognosis and Grade of Patients with Glioma: A Diversification Analysis Based on Transcriptome and Clinical Evidence.
    Zhong S; Fan Y; Wu B; Wang Y; Jiang S; Ge J; Hua C; Zhao G; Chen Y; Xu H
    World Neurosurg; 2018 Nov; 119():e145-e158. PubMed ID: 30053564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of plasma miR-124 expression is a predictive biomarker for prognosis of glioma.
    Wang LQ; Sun W; Wang Y; Li D; Hu AM
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):271-276. PubMed ID: 30657585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma.
    He J; Deng Y; Yang G; Xie W
    J Surg Oncol; 2013 Aug; 108(2):121-5. PubMed ID: 23813496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relaxation-compensated amide proton transfer (APT) MRI signal intensity is associated with survival and progression in high-grade glioma patients.
    Paech D; Dreher C; Regnery S; Meissner JE; Goerke S; Windschuh J; Oberhollenzer J; Schultheiss M; Deike-Hofmann K; Bickelhaupt S; Radbruch A; Zaiss M; Unterberg A; Wick W; Bendszus M; Bachert P; Ladd ME; Schlemmer HP
    Eur Radiol; 2019 Sep; 29(9):4957-4967. PubMed ID: 30809720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IDH mutation status trumps the Pignatti risk score as a prognostic marker in low-grade gliomas.
    Etxaniz O; Carrato C; de Aguirre I; Queralt C; Muñoz A; Ramirez JL; Rosell R; Villà S; Diaz R; Estival A; Teixidor P; Indacochea A; Ahjal S; Vilà L; Balañá C
    J Neurooncol; 2017 Nov; 135(2):273-284. PubMed ID: 28884377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.